XML 85 R73.htm IDEA: XBRL DOCUMENT v3.22.1
Long-term Debt - 2025 Notes (Details)
$ / shares in Units, shares in Millions
1 Months Ended 3 Months Ended
Oct. 31, 2018
USD ($)
shares
$ / shares
Mar. 31, 2022
USD ($)
Mar. 31, 2021
USD ($)
Mar. 31, 2020
USD ($)
Jan. 01, 2022
USD ($)
Dec. 31, 2021
USD ($)
Dec. 31, 2020
USD ($)
Oct. 24, 2018
USD ($)
Oct. 22, 2018
USD ($)
Debt Instrument [Line Items]                  
Stockholders' equity   $ (611,209,000) $ (617,298,000)     $ (693,633,000) $ (619,600,000)    
Amortization of deferred financing costs   539,000 4,370,000            
Cumulative Effect, Period of Adoption, Adjustment                  
Debt Instrument [Line Items]                  
Stockholders' equity           66,383,000      
Common Stock                  
Debt Instrument [Line Items]                  
Stockholders' equity   (916,000) (868,000)     (908,000) (859,000)    
Additional Paid-In Capital                  
Debt Instrument [Line Items]                  
Stockholders' equity   (1,224,250,000) (1,236,847,000)     (1,340,989,000) (1,229,320,000)    
Additional Paid-In Capital | Cumulative Effect, Period of Adoption, Adjustment                  
Debt Instrument [Line Items]                  
Stockholders' equity           106,172,000      
Additional Paid-In Capital | Cumulative Effect, Period of Adoption, Adjustment | Accounting Standards Update 2020-06                  
Debt Instrument [Line Items]                  
Stockholders' equity         $ (106,200,000)        
Retained Earnings (Accumulated Deficit)                  
Debt Instrument [Line Items]                  
Stockholders' equity   592,340,000 598,985,000     626,779,000 $ 589,178,000    
Retained Earnings (Accumulated Deficit) | Cumulative Effect, Period of Adoption, Adjustment                  
Debt Instrument [Line Items]                  
Stockholders' equity           (39,789,000)      
Retained Earnings (Accumulated Deficit) | Cumulative Effect, Period of Adoption, Adjustment | Accounting Standards Update 2020-06                  
Debt Instrument [Line Items]                  
Stockholders' equity         (39,800,000)        
2025 Notes                  
Debt Instrument [Line Items]                  
Debt issuance costs $ 5,900,000                
Senior Notes | 2025 Notes                  
Debt Instrument [Line Items]                  
Face amount $ 172,500,000 172,500,000       $ 172,500,000   $ 22,500,000 $ 150,000,000
Interest rate 1.50%                
Interest expense   600,000 600,000 $ 600,000          
Conversion price (in dollars per share) | $ / shares $ 33.43                
Initial conversion amount (in shares) | shares 5.2                
Carrying amount $ 100,700,000                
Proceeds from issuance of debt 166,600,000                
Debt issuance costs $ 3,400,000                
Amortization of deferred financing costs   $ 300,000 $ 2,400,000            
Repurchase covenant, repurchase price due to fundamental change as percentage of principal amount 100.00%                
Repurchase covenant, sale price as a percentage of conversion price (at least) 130.00%                
Repurchase covenant, trading days, minimum 20 days                
Repurchase covenant, consecutive trading days, minimum 30 days                
Repurchase covenant, repurchase price due to change in sale price as percentage of conversion price 100.00%                
Senior Notes | 2025 Notes | Cumulative Effect, Period of Adoption, Adjustment | Accounting Standards Update 2020-06                  
Debt Instrument [Line Items]                  
Carrying amount         41,300,000        
Senior Notes | 2025 Notes | Common Stock                  
Debt Instrument [Line Items]                  
Proceeds from issuance of debt $ 71,800,000                
Debt issuance costs $ 2,500,000                
Senior Notes | 2025 Notes | Common Stock | Class A Common Stock                  
Debt Instrument [Line Items]                  
Initial conversion rate per $ 1000 principal amount 0.0299135                
Senior Notes | 2025 Notes | Additional Paid-In Capital | Cumulative Effect, Period of Adoption, Adjustment | Accounting Standards Update 2020-06 | Equity Component of Long Term Debt                  
Debt Instrument [Line Items]                  
Stockholders' equity         71,800,000        
Senior Notes | 2025 Notes | Additional Paid-In Capital | Cumulative Effect, Period of Adoption, Adjustment | Accounting Standards Update 2020-06 | Deferred Financing Fees                  
Debt Instrument [Line Items]                  
Stockholders' equity         (2,500,000)        
Senior Notes | 2025 Notes | Retained Earnings (Accumulated Deficit) | Cumulative Effect, Period of Adoption, Adjustment | Accounting Standards Update 2020-06                  
Debt Instrument [Line Items]                  
Stockholders' equity         $ 28,100,000